Published in AIDS Weekly, June 4th, 2001
GlaxoSmithKline district manager Anthony Whitehall confirmed the London-based company reached the agreement to discount a three-drug cocktail that includes the antiretroviral drug AZT. The drug cocktail began lowering AIDS death rates dramatically five years ago. The breakthrough therapy combined AZT - a nucleoside reverse transcriptase inhibitor - with newer drugs known as protease inhibitors.
There are 17,000 reported cases of HIV infection or AIDS in the two-island nation of 1.3 million people, but the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.